You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 36 Degradation of type III and IV collagen associates with outcome when measured in serum from patients with metastatic melanoma treated with immune checkpoint inhibitors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
36 Degradation of type III and IV collagen associates with outcome when measured in serum from patients with metastatic melanoma treated with immune checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023160012
Dec 20234906
Jan 2024801
Feb 20242201
Mar 20242202
Apr 2024801
May 2024800
Jun 20241000
Jul 20241003
Aug 20241001
Sep 2024801
Oct 20241202
Nov 20243202
Dec 2024802
Jan 20251406
Feb 2025300
Mar 2025003
Apr 2025001
May 2025004
Jun 2025002
Total384050